Data monitoring committees and interim monitoring guidelines (Q30582009)

25 June 2017

1 reference

title

Data monitoring committees and interim monitoring guidelines (English)

1 reference

25 June 2017

Freidlin B

1

1 reference

25 June 2017

Korn EL

series ordinal

2

1 reference

25 June 2017

George SL

series ordinal

3

1 reference

25 June 2017

language of work or name

English

0 references

publication date

1 October 1999

1 reference

Contemporary Clinical Trials

25 June 2017

1 reference

25 June 2017

20

1 reference

25 June 2017

5

1 reference

25 June 2017

395-407

1 reference

Some practical aspects of the interim monitoring of clinical trials.

25 June 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2899%2900017-3

7 January 2021

Sequential methods based on the boundaries approach for the clinical comparison of survival times.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2899%2900017-3

7 January 2021

A Multiple Testing Procedure for Clinical Trials

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2899%2900017-3

7 January 2021

Repeated confidence intervals for group sequential clinical trials.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2899%2900017-3

7 January 2021

The what, why and how of Bayesian clinical trials monitoring.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2899%2900017-3

7 January 2021

Data monitoring committees and problems of lower-than-expected accrual or events rates

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2899%2900017-3

7 January 2021

Role of independent data-monitoring committees in randomized clinical trials sponsored by the National Cancer Institute

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2899%2900017-3

7 January 2021

On choosing the number of interim analyses in clinical trials.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2899%2900017-3

7 January 2021

Interim analyses for randomized clinical trials: the group sequential approach

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2899%2900017-3

7 January 2021

Designs for group sequential tests.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2899%2900017-3

7 January 2021

Repeated assessment of results in clinical trials of cancer treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2899%2900017-3

7 January 2021

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2899%2900017-3

7 January 2021

Monitoring clinical trials: conditional or predictive power?

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2899%2900017-3

7 January 2021

Clinical trial designs based on sequential conditional probability ratio tests and reverse stochastic curtailing

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2899%2900017-3

7 January 2021

Group sequential procedures: calendar versus information time

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2899%2900017-3

7 January 2021

Monitoring Treatment Differences in Long-Term Clinical Trials

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2899%2900017-3

7 January 2021

A New Procedure for Group Sequential Analysis in Clinical Trials

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2899%2900017-3

7 January 2021

A reversal of fortune: practical problems in the monitoring and interpretation of an EORTC breast cancer trial

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2899%2900017-3

7 January 2021

10.1016/S0197-2456(99)00017-3

Identifiers

DOI

1 reference

25 June 2017

1 reference